Assessing treatment effectiveness: Determines whether drug levels are sufficient to achieve desired outcomes in treating immune-related diseases. Monitoring patient response: Allows the physician to evaluate how the patient responds to therapy and whether dose adjustments are needed. Detecting potential interactions: Helps identify any adverse reactions or side effects resulting from high or low drug levels. Guiding therapeutic decisions: Assists doctors in making informed decisions regarding continuing or modifying treatment based on detected Adalimumab levels.

Patients receiving Adalimumab treatment: The test evaluates blood drug levels to ensure treatment effectiveness and correct dosing. Patients with chronic conditions: Such as rheumatoid arthritis, Crohn’s disease, psoriasis, and ulcerative colitis, where monitoring drug levels is important for optimal response. Patients with unclear side effects: The test can help determine if high or low Adalimumab levels contribute to adverse effects. Patients not responding to therapy: Measuring drug levels can identify whether dose adjustments are needed in cases of unexpected non-response. Individuals with changes in weight or general health: Changes in weight or health status may affect drug levels, requiring monitoring.

Treatment failure: Persistent worsening of symptoms or lack of improvement despite Adalimumab therapy. Side effects: Unusual symptoms such as allergies, rashes, or inflammation-related signs that may indicate abnormal drug levels. Unexplained symptoms: Chronic fatigue, severe pain, or sudden changes in health that require evaluation of drug levels. Changes in weight: Significant weight loss or gain may affect drug efficacy, necessitating monitoring of Adalimumab levels. Recurrent infections: Frequent or severe infections may suggest impaired immune response. Dose adjustments: When a dosage change is required, testing helps determine the impact on drug levels.

What is Adalimumab? Adalimumab is a biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, psoriasis, and ulcerative colitis. Why is this test performed? The test measures the level of Adalimumab in the blood to assess treatment effectiveness and monitor patient response. How is the test performed? A blood sample is taken and sent to a specialized laboratory, where Adalimumab levels are measured using High-Performance Mass Spectrometry (LCMC-MS). How long does it take to get results? It varies by laboratory, typically from several hours to two days. Is the test painful? Patients may feel a slight pinch or discomfort during blood draw, but the procedure is quick and generally painless. When should this test be done? When the patient is not responding to treatment. When unexplained symptoms appear. When adjusting the medication dose to ensure therapeutic effectiveness. When the patient is not responding to treatment. When unexplained symptoms appear. When adjusting the medication dose to ensure therapeutic effectiveness. Are there any special preparations before the test? Usually no special preparation is needed, but skipping the last Adalimumab dose may be advised to ensure accurate results. Can this test affect treatment decisions? Yes, the results guide the physician in adjusting the dose or changing treatment based on the detected Adalimumab level. What are the risks associated with the test? Risks are minimal, possibly including mild bruising or dizziness, but these are generally minor.

Typically range from 5 to 15 µg/mL. May vary according to the patient’s condition and treatment needs. Levels below 5 µg/mL may indicate insufficient therapy, requiring a review of dosage or treatment plan. Levels above 15 µg/mL may raise concerns about side effects or suboptimal drug response. Regular testing is recommended, especially for long-term treatment, to monitor drug levels and ensure optimal efficacy.

Adalimumab Level Test Price | Lahalak Medical Platform

An advanced test measuring adalimumab concentration in the blood to ensure immune system response and accurately adjust doses for better quality of life and immune health.

Prices starts from: 658.94 SAR

Scientific name: Adalimumab Level Test

Adalimumab level analysis using high-performance liquid chromatography–mass spectrometry (LCMC-MS) is a specialized laboratory test designed to measure adalimumab concentration in blood serum. This test is primarily used to monitor the effectiveness of adalimumab therapy, a biologic medication used to treat various immune-related conditions such as...

Adalimumab Level Test - Adalimumab Therapy Monitor

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 658.94 SAR

Included Services

Adalimumab Level (LCMC-MS) Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Assessing treatment effectiveness: Determines whether drug levels are sufficient to achieve desired outcomes in treating immune-related diseases.
Monitoring patient response: Allows the physician to evaluate how the patient responds to therapy and whether dose adjustments are needed.
Detecting potential interactions: Helps identify any adverse reactions or side effects resulting from high or low drug levels.
Guiding therapeutic decisions: Assists doctors in making informed decisions regarding continuing or modifying treatment based on detected Adalimumab levels.

Recommended groups

Patients receiving Adalimumab treatment: The test evaluates blood drug levels to ensure treatment effectiveness and correct dosing.
Patients with chronic conditions: Such as rheumatoid arthritis, Crohn’s disease, psoriasis, and ulcerative colitis, where monitoring drug levels is important for optimal response.
Patients with unclear side effects: The test can help determine if high or low Adalimumab levels contribute to adverse effects.
Patients not responding to therapy: Measuring drug levels can identify whether dose adjustments are needed in cases of unexpected non-response.
Individuals with changes in weight or general health: Changes in weight or health status may affect drug levels, requiring monitoring.

Symptoms indicative

Treatment failure: Persistent worsening of symptoms or lack of improvement despite Adalimumab therapy.
Side effects: Unusual symptoms such as allergies, rashes, or inflammation-related signs that may indicate abnormal drug levels.
Unexplained symptoms: Chronic fatigue, severe pain, or sudden changes in health that require evaluation of drug levels.
Changes in weight: Significant weight loss or gain may affect drug efficacy, necessitating monitoring of Adalimumab levels.
Recurrent infections: Frequent or severe infections may suggest impaired immune response.
Dose adjustments: When a dosage change is required, testing helps determine the impact on drug levels.

FAQs

What is Adalimumab? Adalimumab is a biologic medication used to treat autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, psoriasis, and ulcerative colitis.
Why is this test performed? The test measures the level of Adalimumab in the blood to assess treatment effectiveness and monitor patient response.
How is the test performed? A blood sample is taken and sent to a specialized laboratory, where Adalimumab levels are measured using High-Performance Mass Spectrometry (LCMC-MS).
How long does it take to get results? It varies by laboratory, typically from several hours to two days.
Is the test painful? Patients may feel a slight pinch or discomfort during blood draw, but the procedure is quick and generally painless.
When should this test be done? When the patient is not responding to treatment. When unexplained symptoms appear. When adjusting the medication dose to ensure therapeutic effectiveness.

Normal Levels

Typically range from 5 to 15 µg/mL.
May vary according to the patient’s condition and treatment needs.
Levels below 5 µg/mL may indicate insufficient therapy, requiring a review of dosage or treatment plan.
Levels above 15 µg/mL may raise concerns about side effects or suboptimal drug response.
Regular testing is recommended, especially for long-term treatment, to monitor drug levels and ensure optimal efficacy.